H2020HORIZONFP7
Fundacio Hospital Universitari Vall D'Hebron - Institut de Recerca
- Country
- ESSpain
- Defence projects
- 0
- Projects, all programmes
- 80
- As coordinator
- 10
- EU contribution (CORDIS)
- EUR 24,576,494
- Active
- 2007 to 2026
Projects
80 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| IABC PROGRAMMEiABC Programme | FP7 | 2015 | Participant | EUR 37,000 |
| NeuroGutEuropean Training in Neural Regulation of Intestinal Function | H2020 | 2014 | Participant | EUR 226,682 |
| METABOSETUnraveling metabolic settings and targeting metabolic enzymes with selective lethality in BRAF and NRAS mutant melanoma tumors | H2020 | 2014 | Coordinator | EUR 173,371 |
| FUTURENANONEEDSFramework to respond to regulatory needs of future nanomaterials and markets | FP7 | 2014 | Participant | EUR 246,185 |
| AGGRESSOTYPEAggression subtyping for improved insight and treatment innovation in psychiatric disorders | FP7 | 2013 | Participant | EUR 80,000 |
| GUIDENANOAssessment and mitigation of nano-enabled product risks on human and environmental health: Development of new strategies and creation of a digital guidance tool for nanotech industries | FP7 | 2013 | Participant | EUR 289,137 |
| MIRNATHERAPYNBLNew epigenetic therapy for high-risk neuroblastoma | FP7 | 2013 | Coordinator | EUR 100,000 |
| PRECIOUSPREventive Care Infrastructure based On Ubiquitous Sensing | FP7 | 2013 | Participant | EUR 214,860 |
| Multi-PARTMulticentre Preclinical Animal Research Team | FP7 | 2013 | Participant | EUR 21,332 |
| ABIRISKAnti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk | FP7 | 2012 | Participant | EUR 353,678 |
| EUROHYP-1European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke | FP7 | 2012 | Participant | EUR 459,046 |
| INCOMEDINCOMING FELLOWSHIPS BIOMEDICINE INSTITUT DE RECERCA VALL D’HEBRON | FP7 | 2012 | Coordinator | EUR 555,984 |
| BEST MSBest EScalation Treatment in Multiple Sclerosis (MS) | FP7 | 2012 | Participant | EUR 460,883 |
| E-PREDICEEarly Prevention of Diabetes Complications in people with Hyperglycaemia in Europe | FP7 | 2012 | Participant | EUR 59,360 |
| EUROCONDOREuropean Consortium for the Early Treatment of Diabetic Retinopathy | FP7 | 2012 | Coordinator | EUR 958,680 |
| PROTBIOFLUIDPROTEOMIC IDENTIFICATION OF BIOMARKERS IN BIOFLUIDS AND IN PRECLINICAL MODELS FOR THE EARLY DIAGNOSIS AND PROGNOSIS OF CANCER (PROT*BIO*FLUID) | FP7 | 2011 | Coordinator | EUR 224,700 |
| EATRISThe European Advanced Translational Research Infrastructure in Medicine | FP7 | 2008 | Participant | Not stated |
| UEPHA-MSUnited Europeans for the Development of Pharmacogenomics in Multiple Sclerosis | FP7 | 2008 | Participant | EUR 188,522 |
| GLIOMAMolecular Mechanisms of Glioma Genesis and Progression | FP7 | 2008 | Participant | EUR 497,998 |
| CANCEROMICSModelling cancer in Caenorhabditis elegans | FP7 | 2007 | Participant | EUR 100,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.